These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
10. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens. Greiner J; Döhner H; Schmitt M Haematologica; 2006 Dec; 91(12):1653-61. PubMed ID: 17145602 [TBL] [Abstract][Full Text] [Related]
11. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines. Raez LE; Santos ES; Mudad R; Podack ER Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of hematological malignancies using dendritic cells. Van de Velde AL; Berneman ZN; Van Tendeloo VF Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412 [TBL] [Abstract][Full Text] [Related]
14. Cancer vaccines: what do we need to measure in clinical trials? Kudrin A Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508 [TBL] [Abstract][Full Text] [Related]
15. Tumor vaccines--application to childhood cancer. Roskrow MA; Zibert A; Souquet M; Dilloo D Klin Padiatr; 1999; 211(4):336-46. PubMed ID: 10472573 [TBL] [Abstract][Full Text] [Related]
16. Tumor antigens as surrogate markers and targets for therapy and vaccines. Dalgleish A; Pandha H Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680 [TBL] [Abstract][Full Text] [Related]